LIQUIDIA CORPORATION - COMMON STOCK

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

10 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024

07 5 2024 07:30:00 提供 Nasdaq GlobeNewswire

Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024

07 5 2024 07:00:01 提供 Nasdaq GlobeNewswire

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

02 4 2024 08:00:10 提供 Nasdaq GlobeNewswire

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder

01 4 2024 05:00:44 提供 Nasdaq GlobeNewswire

Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

13 3 2024 05:00:00 提供 Nasdaq GlobeNewswire

Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

06 3 2024 05:30:41 提供 Nasdaq GlobeNewswire

Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress

30 1 2024 05:30:11 提供 Nasdaq GlobeNewswire

Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder

25 1 2024 05:00:57 提供 Nasdaq GlobeNewswire

Liquidia Corporation Announces Updates to Operations Leadership

19 1 2024 05:30:50 提供 Nasdaq GlobeNewswire

Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims

08 1 2024 07:22:54 提供 Nasdaq GlobeNewswire

Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD

05 1 2024 05:45:01 提供 Nasdaq GlobeNewswire

Liquidia Corporation Announces $100 Million in New Financings

04 1 2024 08:10:24 提供 Nasdaq GlobeNewswire

Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

02 1 2024 05:45:31 提供 Nasdaq GlobeNewswire

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)

20 12 2023 15:56:00 提供 Nasdaq GlobeNewswire

Liquidia Announces Pricing of Public Offering of Common Stock

12 12 2023 06:13:56 提供 Nasdaq GlobeNewswire

Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update

07 11 2023 05:30:26 提供 Nasdaq GlobeNewswire

Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023

31 10 2023 05:30:15 提供 Nasdaq GlobeNewswire

FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label

25 9 2023 15:09:48 提供 Nasdaq GlobeNewswire

United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office

06 9 2023 15:30:02 提供 Nasdaq GlobeNewswire